These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8205245)

  • 1. High-performance liquid chromatographic determination of 3'-hydroxy-5'-(4-isobutyl-1-piperazinyl)benzoxazinorifamycin (KRM-1648) and its deacetyl metabolite in plasma, whole blood, urine and tissue samples in rats.
    Hosoe K; Konishi E; Hidaka T; Yamane T; Yamashita K; Ohashi T
    J Chromatogr B Biomed Appl; 1994 Mar; 653(2):177-86. PubMed ID: 8205245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of KRM-1648, a new benzoxazinorifamycin, in rats and dogs.
    Hosoe K; Mae T; Konishi E; Fujii K; Yamashita K; Yamane T; Hidaka T; Ohashi T
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2749-55. PubMed ID: 9124834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and antimicrobial activity of urinary metabolites of a rifamycin derivative in dog.
    Hosoe K; Mae T; Yamashita K; Fujii K; Yamane T; Hidaka T; Ohashi T
    Xenobiotica; 1996 Mar; 26(3):321-32. PubMed ID: 8730923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic analysis of amphotericin B in plasma, blood, urine and tissues for pharmacokinetic and tissue distribution studies.
    Wang LH; Smith PC; Anderson KL; Fielding RM
    J Chromatogr; 1992 Sep; 579(2):259-68. PubMed ID: 1429973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid-chromatographic determination of rifampicin in plasma and tissues.
    Calleja I; Blanco-Príeto MJ; Ruz N; Renedo MJ; Dios-Viéitez MC
    J Chromatogr A; 2004 Mar; 1031(1-2):289-94. PubMed ID: 15058595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal action at low doses of a new rifamycin derivative, 3'-hydroxy-5'-(4-isobutyl-1-piperazinyl) benzoxazinorifamycin (KRM-1648) on Mycobacterium leprae inoculated into footpads of nude mice.
    Gidoh M; Tsutsumi S; Yamane T; Yamashita K; Hosoe K; Hidaka T
    Lepr Rev; 1992 Dec; 63(4):319-28. PubMed ID: 1479871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method.
    Panchagnula R; Sood A; Sharda N; Kaur K; Kaul CL
    J Pharm Biomed Anal; 1999 Jan; 18(6):1013-20. PubMed ID: 9925337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of rifampin in human plasma by high-performance liquid chromatography with ultraviolet detection.
    Lau YY; Hanson GD; Carel BJ
    J Chromatogr B Biomed Appl; 1996 Feb; 676(1):147-52. PubMed ID: 8852055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic assay for two rifamycin-derived hypocholesterolemic agents in liver and biological fluids.
    Moore DJ; Perrino PJ; Klerer CP; Robertson P
    J Chromatogr; 1993 Feb; 612(2):310-4. PubMed ID: 8468390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metabolism of a rifamycin derivative by animal and human liver microsomes, whole blood and expressed human CYP3A isoform.
    Mae T; Hosoe K; Fujii K; Yamashita K; Yamane T; Hidaka T; Ohashi T
    Xenobiotica; 1996 Aug; 26(8):793-802. PubMed ID: 8879143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic determination of the mucoregulatory drug CO/1408 in rat plasma and urine.
    Girometta MA; Loschi L; Ventura P
    J Chromatogr; 1990 May; 507():227-34. PubMed ID: 2380290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo susceptibility of Mycobacterium ulcerans to KRM-1648, a new benzoxazinorifamycin, in comparison with rifampicin. Anti-mycobacterial activity of KRM-1648.
    Dhople AM
    Arzneimittelforschung; 2001; 51(6):501-5. PubMed ID: 11455683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid determination of rifaximin in rat serum and urine by direct injection on to a shielded hydrophobic stationary phase by HPLC.
    Rao RN; Shinde DD; Agawane SB
    Biomed Chromatogr; 2009 Jun; 23(6):563-7. PubMed ID: 19101925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of a new isoquinolinedione derivative, 7-anilino-5,8-isoquinolinedione, in plasma, urine and tissue homogenates by high-performance liquid chromatography.
    Kim SH; Moon YJ; Ryu CK; Lee MG
    J Pharm Biomed Anal; 2002 Oct; 30(3):519-26. PubMed ID: 12367676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the rifamycin antibiotics rifabutin, rifampin, rifapentine and their major metabolites in human plasma via simultaneous extraction coupled with LC/MS/MS.
    Winchester LC; Podany AT; Baldwin JS; Robbins BL; Fletcher CV
    J Pharm Biomed Anal; 2015 Feb; 104():55-61. PubMed ID: 25481085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified LC-MS/MS method for rapid determination of cycloserine in small-volume human plasma using protein precipitation coupled with dilution techniques to overcome matrix effects and its application to a pharmacokinetic study.
    Mao Z; Wang X; Li B; Jin J; Xu M; Liu Y; Di X
    Anal Bioanal Chem; 2017 Apr; 409(11):3025-3032. PubMed ID: 28224247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated high-performance liquid chromatographic method for the determination of rifampicin in plasma.
    Swart KJ; Papgis M
    J Chromatogr; 1992 Feb; 593(1-2):21-4. PubMed ID: 1639906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the solid-phase extraction of diclofenac sodium, indomethacin and phenylbutazone for their analysis in human urine by liquid chromatography.
    Bakkali A; Corta E; Berrueta LA; Gallo B; Vicente F
    J Chromatogr B Biomed Sci Appl; 1999 Jun; 729(1-2):139-45. PubMed ID: 10410936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urine.
    Chen CL; Lesseley BA; Clarke CR; Roder JD; Sangiah S; Berlin KD; Garrison GL; Scherlag BJ; Lazzara R; Patterson E
    J Chromatogr; 1992 Dec; 583(2):274-9. PubMed ID: 1478994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648.
    Fujii K; Saito H; Tomioka H; Mae T; Hosoe K
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1489-92. PubMed ID: 7492091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.